Baseline serum protein levels associated with survival in axalimogene filolisbac (AXAL)-treated metastatic cervical cancer patients: The GOG/NRG-0265 trial Meeting Abstract
| Authors: | Hayes, S. M.; Petit, R. G.; Balli, D.; Hong, Q.; Huh, W.; Brady, W. E.; Dizon, D.; Powell, M. A.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E.; Higgins, R.; Ueda, S.; McHale, M.; Aghajanian, C.; Monk, B. J. |
| Abstract Title: | Baseline serum protein levels associated with survival in axalimogene filolisbac (AXAL)-treated metastatic cervical cancer patients: The GOG/NRG-0265 trial |
| Meeting Title: | 20th International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 27 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Nov 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2017-11-01 |
| Start Page: | 118 |
| Language: | English |
| ACCESSION: | WOS:000423235201111 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.IGC.0000527296.86225.87 |
| Notes: | Meeting Abstract: ESGO7-0871 -- Also appears on page 767 of the issue -- Source: Wos |
